HIGHLIGHTS
- who: Ashok Chakraborty and colleagues from the AllExcel, Inc, West Haven, CT, United States of America, Nanoviricides, Inc, Shelton, CT, United States University School of Medicine, PAKISTAN have published the research work: Dual effects of NV-CoV-2 biomimetic polymer: An antiviral regimen against COVID-19, in the Journal: PLOS ONE of 25/Nov/2022
- what: The authors focusing on the action mechanism of RDV and how it can be improved in vivo. There aren`t any known acceptable alternatives to the use of live animals to accomplish the purpose of this study. This study . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.